To maintain weight loss: Some use smaller maintenance doses after reaching their goal weight to try to prevent regain, although we do not have much data to show that this is effective
There are numerous studies in the general population and among patients with chronic kidney disease that show glucagon-like peptide-1 (GLP-1) medications are safe and effective for weight loss. Formed in March 2024, the Comprehensive Transplant Centers kidney transplant weight loss program uses a combination of diet, exercise, counseling and weight loss injection medication to help patients reach weight loss goals to make them eligible for transplantation
But while GLP-1s are increasingly becoming mainstream, there are still major gaps in interest and knowledge about how the drugs work
Despite that 510% WL is clinically beneficial, greater WL may be required for the individual to improve or achieve remission of some obesity-related complications [7, 8]
Injectable routes (IP, IM, SC) remain the most rigorously characterised delivery methods
Berkovitch M, Bistritzer T, Milone SD, Perlman K, Kucharczyk W, Olivieri NF